Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Background The use of thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) for detecting
disease recurrence is well validated following total thyroidectomy and radioiodine ablation …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Background: Low-risk patients with differentiated thyroid cancer can be treated with thyroid
lobectomy. Serial measurements of serum thyroglobulin (Tg) are recommended for …

Context The risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in
clinical decision making. The most widely accepted method to assess risk of …

Background: One of the most widely used risk stratification systems for estimating individual
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …